2024-10-11 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis

**Company Overview:** CVS Health Corp is a healthcare company that operates retail pharmacies, pharmacy benefit management services, and health services.

**Performance Analysis:**

1. **Return Comparison:**
    * **CVS Cumulative Return:** -29.42%
    * **S&P 500 (VOO) Cumulative Return:** 134.82%
    * **Return Difference:** -160.87% (Currently, CVS has underperformed the S&P 500 by a significant margin. This represents the 3.74th percentile of its historical underperformance compared to the S&P 500).

2. **Recent Price Action:**
    * **Closing Price:** 65.97
    * **5-Day Moving Average:** 64.93
    * **20-Day Moving Average:** 60.6
    * **60-Day Moving Average:** 59.09
    * **Analysis:** CVS is currently trading above its 5, 20, and 60-day moving averages, indicating potential bullish momentum.

3. **Technical Indicators:**
    * **RSI:** 82.25 (Overbought territory, suggesting potential for a pullback)
    * **PPO:** 1.13 (Positive but high, indicating potential for a correction)
    * **Delta_Previous_Relative_Divergence:** -1.68 (Negative, indicating short-term downtrend)
    * **Expected Return:** 0.0% (The expected return is 0%, suggesting a potential for a neutral to negative outlook in the short term)

4. **Recent Earnings:**
    * **Analysis:** CVS has consistently exceeded earnings estimates in recent quarters. However, the most recent earnings report of 1.83 EPS against a 1.73 estimate suggests that the company's earnings growth may be slowing down.  

5. **News and Recent Issues:**
    * **Market Outlook:** According to FINBOLD, CVS is facing challenges from increased competition in the pharmacy and healthcare sectors. The rising costs of prescription drugs and healthcare services continue to be a concern.
    * **Analyst Opinions:** Most analysts have a "Hold" rating on CVS stock, indicating limited upside potential. 
    * **Performance Highlights:**  CVS is actively investing in digital and technology solutions to enhance its offerings and improve operational efficiency.

**Overall Analysis:**

CVS has experienced significant underperformance compared to the S&P 500. While recent price action suggests potential bullish momentum, technical indicators show overbought conditions and a potential for correction. Recent earnings have exceeded expectations, but growth may be slowing. Analysts have a "Hold" rating on the stock, suggesting limited upside potential. The company faces challenges from competition and rising costs in the healthcare sector. Overall, CVS is currently in a challenging position and investors should exercise caution.

**Recommendations:**

* Investors should closely monitor CVS's earnings reports and any potential changes in the healthcare landscape.
* Consider a "Hold" position until further positive developments in the company's financial performance or market outlook emerge.
* Consider diversifying your portfolio with other investments that may offer better growth potential. 
